Table 4. Descriptive statistics of the glaucoma subgroup receiving a surgical intervention.
Glaucoma 1st surgery (n = 27) | Glaucoma 2nd surgery (n = 10) | |||||
---|---|---|---|---|---|---|
MIGS (n = 16) | TE (n = 9) | CPC (n = 2) | Trabectome (n = 2) | TE (n = 8) | ||
Age (years) | 62.8±12.4 | 52.1±19.7 | 52.5±31.8 | 60.5±13.4 | 55.9±12.8 | |
Gender (male/female) | 16 (100%)/0 (0%) | 8 (88.9%)/ 1 (11.1%) | 2 (100%)/0 (0%) | 2 (100%)/ 0 (0%) | 8 (100%)/0 (0%) | |
Side (right/left) | 9 (56.2%)/7 (43.8%) | 5 (55.6%)/4(44.4%) | 1 (50.0%)/1 (50.0%) | 0 (0%)/2 (100%) | 5 (62.5%)/3 (37.5%) | |
Virus | RV | 7 (43.8%) | 4 (44.4%) | 0 (0%) | 1 (50.0%) | 3 (37.5%) |
CMV | 4 (25.0%) | 2 (22.2%) | 0 (0%) | 1 (50.0%) | 2 (25.0%) | |
HSV | 3 (18.8%) | 1 (11.1%) | 1 (50.0%) | 0 (0%) | 1 (12.5%) | |
VZV | 1 (6.3%) | 1 (11.1%) | 1 (50.0%) | 0 (0%) | 2 (25.0%) | |
MV | 1 (6.3%) | 1 (11.1%) | 0 (0%) | 0 (0%) | 0 (0%) | |
pre-Op VA (logMAR) | 0.21±0.38 | 0.75±0.20 | 0.30±0.71 | 0.70±0.14 | 0.40±0.36 | |
pre-Op IOP (mmHg) | 28.40±9.63 | 28.00±9.96 | 27.00±8.49 | 30.50±13.43 | 27.75±9.48 | |
Number of glaucoma medications | 1.88±0.89 | 2.00±1.00 | 2.00±0.00 | 2.00 ± 0.00 | 2.25±1.04 |
CPC = cyclophotocoagulation, CMV = cytomegalovirus, HSV = herpes simplex virus, MIGS = minimal-invasive glaucoma surgery, MV = multiple virus, TE = trabeculectomy, VA = visual acuity, VZV = varicella-zoster virus